Skip to main content
Equibles

CVA Family Office, LLC

Family Office

Position in MBRX — Moleculin Biotech, Inc.

CIK 1802084 DENVER, CO
Back to MBRX Full portfolio

Position in MBRX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2
+$0 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 18 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CVA Family Office, LLC holds $743,661 across 48 Biotechnology names. MBRX ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 482 $239,423
2 MRNA
Moderna, Inc.
 1,693 $118,560
3 INCY
Incyte Corp
 892 $101,117
4 REGN
Regeneron Pharmaceuticals, Inc.
 143 $89,166
5 ALNY
Alnylam Pharmaceuticals, Inc.
 96 $28,898
6 EXEL
Exelixis, Inc.
 364 $19,805
7 JAZZ
Jazz Pharmaceuticals plc
 81 $19,518
8 ROIV
Roivant Sciences Ltd.
 472 $16,704

All Filings in MBRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2 1
2026-03-31 $2 1
2025-12-31 $3 1
2025-09-30 $18 34
2025-06-30 $10 34
2025-03-31 $33 34
2024-12-31 $57 34
2024-09-30 $96 34
2024-06-30 $119 34
2024-03-31 $200 34
2023-12-31 $429 500
2023-06-30 $289 500
2023-03-31 $480 500
2022-12-31 $530 500
2022-09-30 $530 500
2022-06-30 $725 500
2022-03-31 $890 500
2021-12-31 $930 500
2021-06-30 $1,835 500
2021-03-31 $2,040 500